Advertisement

Das Mammakarzinom Epidemiologie in Österreich, Ätiologie und Prävention

  • Th. Hölzenbein
  • R. Jakesz
Chapter
Part of the Angewandte Onkologie book series (AONKOLOGIE)

Zusammenfassung

Das Mammakarzinom steht an weltweit erster Stelle der malignen Erkrankungen der Frau. Dies trifft auch für Österreich zu, wo die derzeitige Rate an Todesfällen durch das Mammakarzinom 17,3% aller Todesfälle beträgt. Bezüglich der Karzinominzidenz ist besonders eine Zunahme bei jüngeren Frauen zu bemerken. Dies ist der Grund, die Ätiologie dieser Krankheit näher zu beleuchten und eine Wertigkeit der Risikofaktoren vorzunehmen. Tierexperimentell bestehen Hinweise auf Möglichkeiten zur Chemoprävention; es gibt bereits auch Ansätze, diese im klinischen Bereich in Hochrisikogruppen einzusetzen. Studien, die eine Prävention des Mammakarzinoms im humanen System durchführen, sind bislang noch nicht publiziert worden.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Jakesz R, Schemper M, Friedl HP (1985) Das Mammakarzinom in Österreich, Epidemiologie und Risikofaktoren. Wien Klin Wochenschr 98: 1Google Scholar
  2. 2.
    Kurihara M, Aoki K, Tominaga S (1984) Cancer mortality statistics in the world. University of Nagoya, NagoyaGoogle Scholar
  3. 3.
    Mettlin C, Schoenfeld ER (1989) Race, geography, social class and breast cancer. Rev Endocr Rel Cancer 32: 17Google Scholar
  4. 4.
    Buell P (1973) Changing incidence of breast cancer in Japanese-American women. J Nat Cancer Inst 51: 1479PubMedGoogle Scholar
  5. 5.
    Bezwoda WR, Hesdorfer CL, Dansey R, et al (1987) Breast cancer in men. Cancer 60: 1337PubMedCrossRefGoogle Scholar
  6. 6.
    Crichlow RW (1972) Carcinoma of the male breast. Surg Gynecol Obstet 134: 1011PubMedGoogle Scholar
  7. 7.
    Adami H, Hansen J, Jung B, et al (1981) Characteristics of familial breast cancer in Sweden. Cancer 48: 1688PubMedCrossRefGoogle Scholar
  8. 8.
    Sattin RW, Rubin GL, Webster LA, et al (1985) Family history and the risk of breast cancer. JAMA 253: 1908PubMedCrossRefGoogle Scholar
  9. 9.
    Baak JPA, van Dop H, Kurver PHJ, et al (1985) The value of morphometry on classic prognosticators in breast cancer. Cancer 56: 347CrossRefGoogle Scholar
  10. 10.
    Dupont WD, Page DL (1985) Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med 312: 145Google Scholar
  11. 11.
    MacMahon B, Cole P, Brown J (1973) Etiology of human breast cancer: a review. J Nat Cancer Inst 50: 21PubMedGoogle Scholar
  12. 12.
    Henderson BE, Pike MC, Casagrande JT (1981) Breast cancer and the estrogen window hypothesis. Lancet ii: 363Google Scholar
  13. 13.
    Apter D, Vihko R (1983) Early menarche, a risk factor for breast cancer, indicates early onset of ovulatory cycles. J Clin Endocrinol Metab 57: 82PubMedCrossRefGoogle Scholar
  14. 14.
    Henderson BE, Ross RK, Judd HL, et al (1985) Do regular ovulatory cycles increase breast cancer risk? Cancer 56: 1206PubMedCrossRefGoogle Scholar
  15. 15.
    Venturoli S, Porcu E, Fabbri R, et al (1986) Menstrual irregularities in adolescence: hormonal pattern and ovarian morphology. Horm Res 24: 269PubMedCrossRefGoogle Scholar
  16. 16.
    MacMahon B, Trichopoulos D, Brown J, et al (1982) Age, menarche, probability of ovulation and breast cancer risk. Int J Cancer 29: 13PubMedCrossRefGoogle Scholar
  17. 17.
    Henderson BE, Ross R, Bernstein L (1988) Estrogens as a cause of human cancer: the Richard and Hinda Rosenthal foundation award lecture. Cancer Res 48: 246PubMedGoogle Scholar
  18. 18.
    Trichopoulos D, MacMahon B, Cole P (1972) The menopause and breast cancer. J Nat Cancer Inst 48: 605PubMedGoogle Scholar
  19. 19.
    Trichopoulos D, MacMahon B, Cole P (1970) Age at first birth and breast cancer risk. Bull WHO 43: 209Google Scholar
  20. 20.
    Tulinius H, Day NE, Johannesson B, et al (1978) Reproductive factors and risk for breast cancer in Iceland. Int J Cancer 21: 724PubMedCrossRefGoogle Scholar
  21. 21.
    Thein-Hlaing, Thein-Manny-Myint (1978) Risk factors of breast cancer in Burma. Int J Cancer 21: 432PubMedCrossRefGoogle Scholar
  22. 22.
    Yuan JM, Yu MC, Ross RK, et al (1988) Risk factors for breast cancer in Chinese women in Shanghai. Cancer Res 48: 1949PubMedGoogle Scholar
  23. 23.
    Pike MC, Henderson BE, Casagrande JT (1981) Oral contraceptive use and early abortion as risk factors for breast cancer in young women. Br J Cancer 43: 72PubMedCrossRefGoogle Scholar
  24. 24.
    Hadjimichael OC, Boyle CA, Meigs JW (1986) Abortion before first live birth and risk of breast cancer. Br J Cancer 53: 281PubMedCrossRefGoogle Scholar
  25. 25.
    Bernstein L, Depue RH, Ross RK, et al (1986) Higher maternal levels of free estradiol in first compared to second pregnancy: early gestational differences. J Nat Cancer Inst 76: 1035PubMedGoogle Scholar
  26. 26.
    Yu MC, Gerkins VR, Henderson BE (1987) Elevated levels of prolactin in nulliparous women. Br J Cancer 43: 826CrossRefGoogle Scholar
  27. 27.
    Musey VC, Collins DC, Musey PI, et al (1987) Long term effect of a first pregnancy on the secretion of prolactin. N Engl J Med 316: 229PubMedCrossRefGoogle Scholar
  28. 28.
    Muldoon TG (1981) Interplay between estradiol and prolactin in the regulation of steroid hormone receptor levels, nature, and functionality in normal mouse mammary tissue. Endocrinology 109: 1339PubMedCrossRefGoogle Scholar
  29. 29.
    Bernstein L, Pike MC, Ross RK, et al (1985) Estrogen and sex hormone-binding globuline levels in nulliparous and parous women. J Nat Cancer Inst 74: 741PubMedGoogle Scholar
  30. 30.
    Brinton LA, Hoover R, Fraumeni JF (1986) Menopausal estrogens and breast cancer risk: an expanded case control study. Br J Cancer 54: 825PubMedCrossRefGoogle Scholar
  31. 31.
    Wingo PA, Layde PM, Lee NC, et al (1987) The risk of breast cancer in premenopausal women who have used estrogen replacement therapy. JAMA 257: 209PubMedCrossRefGoogle Scholar
  32. 32.
    Kelsey JL, Fisher DB, Holford TR, et al (1981) Exogenous estrogens and other factors in the epidemiology of breast cancer. J Nat Cancer Inst 67: 327PubMedGoogle Scholar
  33. 33.
    Hoover R, Gray LA Jr, Cole P, et al (1976) Menopausal estrogens and breast cancer. N Engl J Med 295: 401PubMedCrossRefGoogle Scholar
  34. 34.
    Mills PK, Beeson WL, Phillips RL, et al (1989) Prospective study of exogenous hormone use and breast cancer in seventh-day-adventists. Cancer 64: 591PubMedCrossRefGoogle Scholar
  35. 35.
    Bergkvist L, Adami HO, Persson I, et al (1989) The risk of breast cancer after estrogen and estrogen-progestin replacement. N Engl J Med 321: 293PubMedCrossRefGoogle Scholar
  36. 36.
    Persson I, Adami HO, Bergkvist L, et al (1989) Risk of endometrial cancer after treatment with estrogens alone or in conjunction with progesterons: results of a prospective study. Br J Med 298: 147CrossRefGoogle Scholar
  37. 37.
    Key TJ, Pike MC (1988) The role of estrogens and progestagens in the epidemiology and prevention of breast cancer. Eur J Cancer Clin Oncol 24: 29PubMedCrossRefGoogle Scholar
  38. 38.
    The Cancer and Steroid Hormone Study of the Centers for Disease Control and the National Institute of Child Health and Human Development (1986) Oral contraceptive use and the risk of breast cancer. N Engl J Med 315: 405CrossRefGoogle Scholar
  39. 39.
    Paul C, Skegg DCG, Spears GFS, et al (1986) Oral contraceptives and breast cancer: a national study. Br Med J 293: 723CrossRefGoogle Scholar
  40. 40.
    Romieu I, Willett WC, Colditz GA, et al (1989) Prospective study of oral contraceptive use and risk of breast cancer in women. J Nat Cancer Inst 81: 1313PubMedCrossRefGoogle Scholar
  41. 41.
    Pike MC, Henderson BE, Krailo MD (1983) Breast cancer in young women and use of oral contraceptives: possible effect of formulation and age at use. Lancet ii: 926Google Scholar
  42. 42.
    McPherson K, Weil A, Vessey MP, et al (1983) Oral contraceptives and breast cancer risk. Lancet ii: 926 (letter)Google Scholar
  43. 43.
    Meirik O, Lund E, Adami HO, et al (1986) Oral contraceptives and breast cancer in young women. Lancet ii: 1414Google Scholar
  44. 44.
    Olsson H, Möller TR, Ranstam J (1989) Early oral contraceptive use and breast cancer among premenopausal women: final report from a study in Southern Sweden. J Nat Cancer Inst 81: 1000PubMedCrossRefGoogle Scholar
  45. 45.
    Greenberg ER, Barnes AB, Ressequie L, et al (1984) Breast cancer in mothers given diethyl-stilbestrol in pregnancy. N Engl J Med 311: 1393PubMedCrossRefGoogle Scholar
  46. 46.
    Depue RH, Pike MC, Henderson BE (1983) Estrogen exposure during gestation and the risk of testicular cancer. J Nat Cancer Inst 71: 115Google Scholar
  47. 47.
    Holm LE, Callmer E, Hjalmar ML, et al (1989) Dietary habits and prognostic factors in breast cancer. J Nat Cancer Inst 81: 1218PubMedCrossRefGoogle Scholar
  48. 48.
    MacMahon B (1982) Incidence trends in North America, Japan, and Hawaii. In: Magnus K (ed) Trends in cancer incidence. McGraw-Hill, New York, p 249Google Scholar
  49. 49.
    Bjarnason O, Day N, Snædal G, et al (1974) The effect of year of birth on the breast cancer age-incidence curve in Iceland. Int J Cancer 13: 689PubMedCrossRefGoogle Scholar
  50. 50.
    Staszewski J, Haenszel W (1965) Cancer mortality among the Polish-born in the United States. J Nat Cancer Inst 35: 291PubMedGoogle Scholar
  51. 51.
    Willet WC, MacMahon B (1984) Diet and cancer — an overview, part II. N Engl J Med 310: 697CrossRefGoogle Scholar
  52. 52.
    Toniolo P, Riboli E, Protta F, et al (1989) Calorie-providing nutrients and risk of breast cancer. J Nat Cancer Inst 81: 278PubMedCrossRefGoogle Scholar
  53. 53.
    Phillips RL (1975) Role of life style and dietary habits in risk of cancer among seventh-day-adventists. Cancer Res 35: 3513PubMedGoogle Scholar
  54. 54.
    Willett WC, Stampfer MJ, Colditz GS, et al (1987) Dietary fat and the risk of breast cancer. N Engl J Med 316: 22PubMedCrossRefGoogle Scholar
  55. 55.
    Comittee on Diet, Nutrition, and Cancer, National Academy of Sciences (1982) Diet, nutrition and cancer. Assembly of Life Sciences. Nat Acad Press, Washington, DCGoogle Scholar
  56. 56.
    Young ThB (1989) A case control study of breast cancer and alcohol consumption habits. Cancer 64: 552PubMedCrossRefGoogle Scholar
  57. 57.
    Harvey EB, Schairer C, Brinton LA, et al (1987) Alcohol consumption and breast cancer. J Nat Cancer Inst 78: 657PubMedGoogle Scholar
  58. 58.
    Hiatt RA, Klatsky AL, Armstrong MA (1988) Alcohol consumption and the risk of breast cancer in a prepaid health plan. Cancer Res 48: 2284Google Scholar
  59. 59.
    Toniolo P, Riboli E, Protta F, et al (1989) Breast cancer and alcohol consumption. A case-control study in Northern Italy. Cancer Res 49: 5203PubMedGoogle Scholar
  60. 60.
    Bjelke EA (1975) Dietary vitamin A and lung cancer. Int J Cancer 15: 561PubMedCrossRefGoogle Scholar
  61. 61.
    Graham S (1984) Epidemiology of retinoids and cancer. J Nat Cancer Inst 73: 1423PubMedGoogle Scholar
  62. 62.
    Marubini E, Decarli A, Costa A, et al (1988) The relationship of dietary intake and serum levels of retinol and beta-carotine with breast cancer. Cancer 61: 173PubMedCrossRefGoogle Scholar
  63. 63.
    Schrauzer GN, White DA, Schneider CJ (1977) Cancer mortality correlation studies III. Statistical associations with dietary selenium intakes. Bioanorgan Chem 7: 23CrossRefGoogle Scholar
  64. 64.
    McConnell KP, Jager RM, Bland KI, et al (1980) The relationship of dietary selenium and breast cancer. J Surg Oncol 15: 67PubMedCrossRefGoogle Scholar
  65. 65.
    Broghammer WL Jr, McConnel KP, Blotcky AJ (1976) Relationship between serum selenium levels and patients with carcinoma. Cancer 37: 1384Google Scholar
  66. 66.
    Jacobs MM, Matney TS, Griffin AC (1977) Inhibitory effects of selenium on the mutagenicity of 2-acetylaminofluorine ( AAF) and AAF derivates. Cancer Lett 7: 319CrossRefGoogle Scholar
  67. 67.
    Schrauzer GN, Ishmael D (1974) Effects of selenium and of arsenic on the genesis of spontaneous mammary tumors in inbred C3H mice. Ann CI in Lab Sci 4: 441Google Scholar
  68. 68.
    Land CE, Boice JD, Shore RE, et al (1980) Breast cancer risk from low-dose exposures to ionizing radiation: results of parallel analysis of three exposed populations of women. J Nat Cancer Inst 65: 353PubMedGoogle Scholar
  69. 69.
    Tokunaga M, Land CE, Yamamoto T, et al (1987) Incidence of female breast cancer among atomic bomb survivors, Hiroshima and Nagasaki, 1950–1980. Radiat Res 112: 243PubMedCrossRefGoogle Scholar
  70. 70.
    Morin MM, Visscher W, Harris BSH III, et al (1989) Breast cancer in women with scoliosis exposed to multiple diagnostic X-rays. J Nat Cancer Inst 81: 1307PubMedCrossRefGoogle Scholar
  71. 71.
    Hildreth NG, Shore RE, Dvoretsky PM (1989) The risk of breast cancer after irradiation of the thymus in infancy. N Engl J Med 19: 1281CrossRefGoogle Scholar
  72. 72.
    Miller AB, Howe GR, Sherman GJ, et al (1989) Mortality from breast cancer after irradiation during fluoroscopic examinations in patients being treated for tuberculosis. N Engl J Med 19: 1285CrossRefGoogle Scholar
  73. 73.
    Jensen R, Page DL, Dupont WD, et al (1989) Invasive breast cancer risk in women with sclerosing adenosis. Cancer 64: 1977PubMedCrossRefGoogle Scholar
  74. 74.
    Rosen PR, Groshen S, Kinne DW, et al (1989) Contralateral breast carcinoma: an assessment of risk and prognosis in stage I (Ti NOMO) and stage II (Ti N1 M0) patients with 20-year follow up. Surgery 106: 904PubMedGoogle Scholar
  75. 75.
    Storm HH, Jensen OM (1986) Risk of contralateral breast cancer in Denmark. Int J Cancer 54: 483Google Scholar
  76. 76.
    Chaudary MA, Millis RR, Hoskins EOL, et al (1984) Bilateral primary breast cancer: a prospective study of disease incidence. Br J Surg 71: 711PubMedCrossRefGoogle Scholar
  77. 77.
    Bertram JS, Kolonel LN, Meyskens FL Jr (1987) Rationale and strategies for chemoprevention in humans. Cancer Res 47: 3012PubMedGoogle Scholar
  78. 78.
    Graham S, Marshall J, Mettlin C, et al (1982) Diet in the epidemiology of breast cancer. Am J Epidemiol 116: 68PubMedGoogle Scholar
  79. 79.
    Thompson HJ, Becci PJ, Brown CC, et al (1979) Effect of the duration of retinyl acetate feeding on inhibition of 1-methyl-1-nitrosourea induced mammary carcinogenesis in the rat. Cancer Res 39: 3977PubMedGoogle Scholar
  80. 80.
    Welsh CW, Goodrich-Smith M, Brown CK, et al (1981) Enhancement by retinyl acetate of hormone-induced mammary tumorigenesis in female GR/A mice. J Nat Cancer Inst 67: 935Google Scholar
  81. 81.
    Kamm JJ, Ashenfelter KO, Erhmann CW (1984) Preclinical and clinical toxicity of selected retinoids. In: Sporn MB, Roberts AB, Goodman D (eds) The retinoids. Academic Press, New York, p 287Google Scholar
  82. 82.
    Cameron E, Pauling L, Leibovitz B, et al (1979) Ascorbic acid and cancer: a review. Cancer Res 39: 663PubMedGoogle Scholar
  83. 83.
    Willett WC, Polk BF,Underwood BA, et al (1984) Relation of serum vitamins A, E, and carotinoids to the risk of cancer. N Engl J Med 310: 430PubMedCrossRefGoogle Scholar
  84. 84.
    Summerfield FW, Tappel AL (1984) Vitamin E protects against methyl ethyl ketone peroxide-induced peroxidative damage to rat brain DNA. Mutat Res 122: 113Google Scholar
  85. 85.
    Cook MG, McNamara P (1980) Effect of dietary vitamin E on dimethylhydracine induced colonic tumors in mice. Cancer Res 40: 1329Google Scholar
  86. 86.
    Staehlin HB, Rosel F, Bess E, et al (1984) Cancer, vitamins and plasma lipids: prospective Basel study. J Nat Cancer Inst 73: 1463Google Scholar
  87. 87.
    Willet WC, MacMahon B (1984) Diet and cancer — an overview, part I. N Engl J Med 310: 633CrossRefGoogle Scholar
  88. 88.
    Tabär L, Fagerberg G, Gad A, et al (1985) Reduction in breast cancer mortality by mass screening with mammography: first results of a randomized trial in two Swedish countries. Lancet i: 829Google Scholar
  89. 89.
    UK Trial of Early Detection of Breast Cancer Group (1988) First results on mortality reduction in the UK trial of early detection of breast cancer. Lancet ii: 411Google Scholar
  90. 90.
    Verbeek A, Hendricks J, Holland R, et al (1984) Reduction of breast cancer mortality through mass screening with modern mammography: first results of the Nijmegen project, 1975–1981. Lancet i: 1224Google Scholar
  91. 91.
    Shapiro S, Venet W, Strax P (1988) Periodic screening for breast cancer: the Health Insurance Plan Project, 1963–1986, and its sequelae. The John Hopkins University Press, BaltimoreGoogle Scholar
  92. 92.
    Beex LV, Koenders AJ (1984) Is hormonal responsiveness in breast cancer age dependent? Rev Endocr Rel Cancer 19: 5Google Scholar
  93. 93.
    Bonadonna G, Rossi A, Valagussa P (1985) Adjuvant CMF chemotherapy in operable breast cancer: ten years later. Lancet i: 976Google Scholar
  94. 94.
    International Agency for Research on Cancer (1979) Sex hormones (II). IARC Monogr Eval Carcinog Risk Chem Hum 21: 5Google Scholar
  95. 95.
    MacMahon B (1989) Cancer of the breast, hypothesis in cancer. In: DeVita VT, Hellman S, Rosenberg S (eds) Principles and practice of oncology. Lippincott, Philadelphia Toronto, p 95Google Scholar
  96. 96.
    Cuzick J, Wang DY, Bulbrook RD (1986) The prevention of breast cancer. Lancet 1: 83PubMedCrossRefGoogle Scholar
  97. 97.
    Nolvadex Adjuvant Trial Organization (1985) Controlled trial of tamoxifen as a single adjuvant agent in management of early breast cancer. Lancet i: 836Google Scholar
  98. 98.
    Palli D, del Turco MR, Buetti E, et al (1986) A case control study of the efficacy of a non-randomized breast cancer screening program in Florence ( Italy ). Int J Cancer 38: 501PubMedCrossRefGoogle Scholar
  99. 99.
    Strax P (1989) The Health Insurance Plan of New York study, clinical aspects. Cancer 64: 2641PubMedCrossRefGoogle Scholar
  100. 100.
    Brown H (1989) Motivating women to participate in breast cancer detection. Cancer 64: 2690PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag/Wien 1992

Authors and Affiliations

  • Th. Hölzenbein
  • R. Jakesz

There are no affiliations available

Personalised recommendations